Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Antonello Rana"'
Autor:
Giacoma De Tullio, Vincenza De Fazio, Nicola Sgherza, Carla Minoia, Simona Serratì, Francesca Merchionne, Giacomo Loseto, Angela Iacobazzi, Antonello Rana, Patrizia Petrillo, Nicola Silvestris, Pasquale Iacopino, Attilio Guarini
Publikováno v:
Molecules, Vol 19, Iss 9, Pp 14723-14781 (2014)
MicroRNAs (miRNAs) are small non-coding RNAs that control the expression of many target messenger RNAs (mRNAs) involved in normal cell functions (differentiation, proliferation and apoptosis). Consequently their aberrant expression and/or functions a
Externí odkaz:
https://doaj.org/article/3654af7a23854c48bdfb33a5b2d06a5f
Autor:
Bruno Fattizzo, Nicola Cecchi, Edoardo Tamellini, Francesca Morelli, Ilaria Tanasi, Maria Di Perna, Simona Raso, Angelo Gardellini, Dorela Lame, Marica Laurino, Olga Mulas, Antonello Rana, Paola Bianchi, Wilma Barcellini
Publikováno v:
Blood. 140:2451-2453
Autor:
Simona Serratì, Vincenza De Fazio, Angela Iacobazzi, Francesca Merchionne, Nicola Sgherza, Carla Minoia, Attilio Guarini, Giacoma De Tullio, Pasquale Iacopino, Patrizia Petrillo, Antonello Rana, Giacomo Loseto, Nicola Silvestris
Publikováno v:
Molecules
Molecules, Vol 19, Iss 9, Pp 14723-14781 (2014)
Molecules, Vol 19, Iss 9, Pp 14723-14781 (2014)
MicroRNAs (miRNAs) are small non-coding RNAs that control the expression of many target messenger RNAs (mRNAs) involved in normal cell functions (differentiation, proliferation and apoptosis). Consequently their aberrant expression and/or functions a
Autor:
Nicola Sgherza, Giacomo Loseto, Rosa Angarano, Giacoma De Tullio, Angela Iacobazzi, Elena Ranieri, Antonello Rana, Attilio Guarini, Michele Guida, Margherita Gigante, Pasquale Iacopino, Sabino Strippoli, Vincenza De Fazio, Simona Serratì, Carla Minoia
Publikováno v:
Blood. 124:3840-3840
The mutual interactions between the host immune system and cancer cells may either promote or control oncogenesis. Cancer immunotherapies remain viable approaches to sustain patient survival. However, positive clinical response of phase I/II clinical
Autor:
Rosa Angarano, Vincenza De Fazio, Ines Abbate, Giacomo Loseto, Angela Iacobazzi, Vito Cafagna, Attilio Guarini, Carla Minoia, Antonello Rana, Angela La Pietra, Giacoma De Tullio, Vito Michele Garrisi, Simona Serratì, Nicola Sgherza
Publikováno v:
Blood. 124:5515-5515
BACKGROUND. Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by an aberrant protein (BCR–ABL) which is a constitutively active tyrosine kinase. According to the latest ELN recommendations for the management of CML, mole
Autor:
Vincenza De Fazio, Antonello Rana, Giacomo Loseto, Angela Iacobazzi, Attilio Guarini, Nicola Sgherza, Rosa Angarano, Giacoma De Tullio, Simona Serratì
Publikováno v:
Blood. 124:5711-5711
Multiple myeloma (MM) is a clonal disease characterized by an increased number of malignant plasma cells (M-PCs) that accumulate in bone marrow (BM). High dose of chemiotherapy followed by autologous peripheral blood stem cell transplantation produce
Autor:
Giacoma De Tullio, Carla Minoia, Simona Serratì, Francesca Merchionne, Giacomo Loseto, Angela La Pietra, Antonello Rana, Angela Iacobazzi, Pasquale Iacopino, Attilio Guarini
Publikováno v:
Blood. 122:4506-4506
Background Many aspects of lymphoma pathophysiology indicate mutual interactions between the host immune system and lymphoma cells. These interactions may either promote or control lymphomagenesis. An unconventional subset of CD4-CD8- double-negative